BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 21514793)

  • 1. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.
    Brissos S; Dias VV; Balanzá-Martinez V; Carita AI; Figueira ML
    Schizophr Res; 2011 Jul; 129(2-3):133-6. PubMed ID: 21514793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.
    Alessandrini M; Lançon C; Fond G; Faget-Agius C; Richieri R; Faugere M; Metairie E; Boucekine M; Llorca PM; Auquier P; Boyer L
    Schizophr Res; 2016 Mar; 171(1-3):27-34. PubMed ID: 26781001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia.
    Chang WC; Chan TC; Chen ES; Hui CL; Wong GH; Chan SK; Lee EH; Chen EY
    Schizophr Res; 2013 Jan; 143(1):107-15. PubMed ID: 23151398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in memory performance over a 12-month period in relation to achieving symptomatic remission after a first-episode psychosis.
    Benoit A; Bodnar M; Malla AK; Joober R; Bherer L; Lepage M
    Schizophr Res; 2014 Mar; 153(1-3):103-8. PubMed ID: 24512651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disconnected and underproductive speech in schizophrenia: unique relationships across multiple indicators of social functioning.
    Bowie CR; Gupta M; Holshausen K
    Schizophr Res; 2011 Sep; 131(1-3):152-6. PubMed ID: 21561739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive functioning during full and partial remission (positive and negative symptomatic remission) of schizophrenia.
    Braw Y; Benozio A; Levkovitz Y
    Schizophr Res; 2012 Dec; 142(1-3):122-8. PubMed ID: 23127380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech disturbances and quality of life in schizophrenia: differential impacts on functioning and life satisfaction.
    Tan EJ; Thomas N; Rossell SL
    Compr Psychiatry; 2014 Apr; 55(3):693-8. PubMed ID: 24315617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning related to quality of life in schizophrenia.
    Matsui M; Sumiyoshi T; Arai H; Higuchi Y; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):280-7. PubMed ID: 17884266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K; Aki H; Tomotake M; Iga J; Numata S; Motoki I; Izaki Y; Tayoshi S; Kinouchi S; Sumitani S; Tayoshi S; Takikawa Y; Kaneda Y; Taniguchi T; Ishimoto Y; Ueno S; Ohmori T
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):404-11. PubMed ID: 18778437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in stable schizophrenia: the relative contributions of disorganization and cognitive dysfunction.
    Sigaudo M; Crivelli B; Castagna F; Giugiario M; Mingrone C; Montemagni C; Rocca G; Rocca P
    Schizophr Res; 2014 Mar; 153(1-3):196-203. PubMed ID: 24485197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social cognition and quality of life in schizophrenia.
    Maat A; Fett AK; Derks E;
    Schizophr Res; 2012 May; 137(1-3):212-8. PubMed ID: 22406280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.